Thursday, November 9, 2017 at 9:00PM EST - Recording Available
The IASLC Atlas of PD-L1 Immunohistochemistry Testing in Lung Cancer is a new resource for understanding programmed cell death ligand-1 (PD-L1) immunohistochemistry (IHC) assays.
October 10, 2017 at 9:00PM EDT - Recording Available
Classification of NSCLC has been rapidly evolving, owing in large part to increased attention to histologic features and common molecular alterations.
October 9, 2017 at 7:00PM CEST - Recording Available
This webinar will highlight advances in the management of lung cancer reported during the recent European Society for Medical Oncology Congress ( ESMO 2017).
September 21, 2017 at 1:00 PM EST; September 21, 2017 at 6:00 PM EST - Recording Available
These live webinars are intended to help pathologists, scientists and physicians better understand the background, protocol and interpretation of results of ALK and ROS1 testing for NSCLC patients.
September 21, 2017 at 6:00PM HKT - Recording Available
This program will provide an updated view of the optimal management of ALK Positive Lung Cancer.
September 15, 2017 at 7:00PM CEST - Recording Available
In this webinar will discuss the optimal management of patients affected with brain metastases from non-small cell lung cancer (NSCLC).
September 6, 2017 at 9:00PM EDT - Recording Available
The National Lung Screening Trial provided clear evidence of a lung cancer mortality reduction in high-risk patients who undergo screening with low-dose CT.
Wednesday August 16, 2017, at 9:00PM EDT - Recording Available
This one hour webinar focuses on squamous cell carcinoma of the lung.
Tuesday, August 8, 2017, at 9:00PM EDT - Recording Available
This one hour webinar will explore the use of proton therapy for lung cancer.
Tuesday, August 1, 2017, at 7:00 PM CEST - Recording Available
In recent years checkpoint inhibitors, particularly PD-1/PD-L1 inhibitors, have become an important component of the management of advanced NSCLC patients.